The tour was hosted by the Black Greek Letter Consortium (BGLC), which is made up of the nine National Pan-Hellenic Council (NPHC) organizations, also known as the Divine Nine (D9). These historically Black fraternities and sororities support the mission of the All of Us Research Program to advance health equity for those considered underrepresented in biomedical research.
Developed by the National Institutes of Health (NIH), the All of Us Research Program looks to enable a new era in medicine in which researchers, health care professionals, and patients work together to develop individualized care.
Click HERE to learn more about All of Us.
Enjoy a short recap below and see the full recap video HERE.
HOST: PAUL QUINN COLLEGE
This historic conversation with medical and research professionals, the Divine Nine, Yardtalk 101, Paul Quinn Counseling Department, Jade E. Mathis and other All of Us partners discussed the importance of research with a focus on mental health. The Keynote Speaker, Dr. Karriem Watson, All of Us Chief Engagement Officer, amplified that together we can help change the future of medicine for the Black community and other marginalized communities by diversifying the database and the Researchers.
The Dallas Metroplex NPHC Councils hosted the Community Day event on Saturday, February 26 in partnership with All of Us, DREF, National Association of Hispanic Nurses, Baylor Scott & White, and OurCalling.
Friendship-West Baptist Church hosted the virtual faith-based service on Sunday, February 26, which included the debut of their Divine Nine Ensemble. The message was titled “Anything is Possible” and aligned to being Rooted in Resilience. Click be “Watch Worship Service” below to watch the service.
The DREF awareness campaign entitled, “Research Matters: Creating Possibilities to Achieve Health and Wellness for “All of Us” focuses on the objective of creating awareness about how research matters in closing the health disparities gap. African Americans continue to have the highest incidence, prevalence, and mortality rates from chronic diseases, such as cardiovascular disease, diabetes, obesity, hypertension, mental health, and HIV/AIDS, yet they contribute to only five percent of clinical trial participants in America.